IT Orange | IT桔子

Farmerline raises $14.4 million in Series A funding

Farmerline is an agricultural technology service provider that works through agricultural dealers to ensure the supply of high-quality fertilizers and seeds to farmers. The cooperative retailers use the company’s Mergdata (a dedicated AI technology platform for supply chain intelligence) to provide farmers with digital services, Provides the data needed to forecast the demand for farm

Farmerline raises $14.4 million in Series A funding Read More »

LINE MAN Wongnai secures $265 million in Series B financing

LINE MAN Wongnai is a food delivery platform, formed by the merger of local food delivery platform LINE MAN and restaurant review platform Wongnai. Currently, in addition to food delivery, LINE MAN Wongnai also operates grocery delivery, taxi services, errands, restaurant reviews, restaurant solutions (POS) and other businesses. LINE MAN Wongnai has recently received a

LINE MAN Wongnai secures $265 million in Series B financing Read More »

Zhongke Qingzi won the angel round investment of Guicheng Science and Technology Direct Investment Fund

Zhongke Qingzi is a clinical diagnostic mass spectrometry reagent developer, based in the field of precision medicine, focusing on the R&D and production of clinical diagnostic mass spectrometry reagents and providing third-party medical testing services. A few days ago, Zhongke Qingzi received an angel round of investment of 5 million yuan. The investor is the

Zhongke Qingzi won the angel round investment of Guicheng Science and Technology Direct Investment Fund Read More »

Biaoxin Bio completed Pre-A+ round of financing

Biaoxin Bio is a protein degradation drug developer, focusing on the development of first-in-class or best-in-class protein degradation drugs in the field of oral anti-tumor and autoimmune diseases. It has established a dual-platform cross-fusion of molecular glue and PROTAC. The drug development platform, the product line includes molecular glue and proteolysis targeting chimera, covering multiple

Biaoxin Bio completed Pre-A+ round of financing Read More »

Lihao Semiconductor completes 2.2 billion B round of financing

Lihao Semiconductor is a semiconductor material research and development company, mainly engaged in the process technology research and development, production, sales and related supporting new energy business of high-purity crystalline silicon and other semiconductor materials. Committed to building a “green boutique project”, creating a high-tech enterprise with green manufacturing and clean development, and creating an

Lihao Semiconductor completes 2.2 billion B round of financing Read More »

Huibo Yuntong Shenzhen Stock Exchange Public Offering

Huibo Yuntong is a company specializing in the field of IT services, dedicated to software outsourcing, intelligent hardware testing and certification, and mobile communication terminal testing and evaluation services. Today Huibo Yuntong Shenzhen Stock Exchange’s public offering. This article is reproduced from: https://www.itjuzi.com/pre-ipo?comname=%E6%85%A7%E5%8D%9A%E4%BA%91%E9%80%9A This site is for inclusion only, and the copyright belongs to the

Huibo Yuntong Shenzhen Stock Exchange Public Offering Read More »

Greatpower Nickel Cobalt Hong Kong Stock Exchange submits a prospectus

Greatpower Nickel Cobalt is a power battery material provider. The company’s main business includes basic materials such as cobalt, nickel and manganese, ternary precursors, lithium battery cathode materials, and power battery echelon recycling. It is committed to building a new energy power battery industry production circle. Today, Gepai Nickel and Cobalt Hong Kong Stock Exchange

Greatpower Nickel Cobalt Hong Kong Stock Exchange submits a prospectus Read More »

Zhenhe Technology Hong Kong Stock Exchange submitted a prospectus

Zhenhe Technology is a company in the field of medical and health care, with next-generation sequencing technology and bioinformatics as the core, engaged in non-invasive personalized precision diagnosis and treatment of tumors and companion diagnosis, and is committed to becoming a leader in improving the quality of life of tumor patients. Zhenhe Technology Hong Kong

Zhenhe Technology Hong Kong Stock Exchange submitted a prospectus Read More »